Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026
Leading respiratory researcher Dr. Sebastian Johnston to present new results that demonstrate vapendavir treatment reduces inflammatory biomarkers in COPD patients COLLEGE PARK, Ga., July 7, 2026 /PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to...
Leading respiratory researcher Dr. Sebastian Johnston to present new results that demonstrate vapendavir treatment reduces inflammatory biomarkers in COPD patients COLLEGE PARK, Ga., July 7, 2026 /PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.